Injection of colchicine into the lateral cerebral ventricle of the rat was found to induce a paradoxical translocation of two lysosomal enzymes, dipeptidyl peptidase II (Dpp II) and acid phosphatase, from the soma of neurons to the dendrites.
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complexities introduced by the presence of ribosomes in the larger dendritic branches near the cell body, where presumably protein synthesis could take place. Dendritrc transport has been studied by means of intracellular injections of radiolabeled precursors combined with autoradiography. lontophoretic injections of 3H-glycine into motoneurons of the spinal cord produce a pattern of labeling consistent with the fast transport of proteins from the soma to the dendrites (Globus et al., 1968) . The labeling patterns observed after injections of precursors such as 3H-leucine, 35S-sulfate, 3H-choline, and 3H-orotic acid are also compatible with fast and slow dendritic transport of proteins, glycoproteins, acid mucopolysaccharides, phospholipids, and RNA (Kreutzberg and Schubert, 1973, 1975; Kiss, 1977) . Evidence for the rapid bidirectional transport of proteins in dendrites has also been obtained from in vitro horseradish peroxidase injections into cell bodies or dendrites of pyramidal neurons in the hippocampal formation of the rat (Lynch et al., 1975) . Dendritic transport, like that in axons, can be blocked by colchicine and similar drugs which disrupt microtubule polymerization (Schubert et al., 1972) . Thus, it appears that dendritic transport shares in common many of the properties described for axonal transport.
The effects of colchicine on nervous tissue have attracted considerable attention, since this drug blocks axonal transport but does not interfere with protein synthesis (James et al., 1970) . Thus, injections of colchicine cause enzymes and organelles that are normally transported to nerve terminals to accumulate in the cell body and proximal dendrites (Fonnum et al., 1973; Ribak et al., 1978; Grafstein and Forman, 1980) . As a result, colchicine injections have proved invaluable in the localization of normally undetectable peptides and enzymes with immunocytochemical methods (Ribak et al., 1978; lnnis et al., 1979) .
In a prevrous study we showed that dipeptidyl peptidase II (E.C. 3.4.14.2; Dpp II), an acid peptidase which cleaves two amino acids from the amino terminal end of peptides, was highly localized to a small number of neuronal populations in the rat brain (Gorenstein et al., 1981) . Intense staining, mainly associated with cell bodies and to a lesser extent with dendrites, was observed in the mitral cell layer of the olfactory bulb, anterior dorsal nucleus of the thalamus, mesencephalic nucleus of the trigeminal nerve, red nucleus, central nucleus of the inferior colliculus, inferior olivary nucleus, stratum album of the superior colliculus, and Purkinje cells and deep nuclei of the cerebellum. In an attempt to enhance the visualization of this enzyme in all neuronal populations, including those with low Dpp II activity, we reasoned that intracerebroventricular injections of colchicine would produce a detectable enrichment of Dpp II in cell bodies. In this paper we report a paradoxical effect of colchicine on the intraneuronal localization of two lysosomal enzymes: Dpp Ii and acid phosphatase. are also posltlve for Dpp II (arrows) In the external plexiform layer and the granule cell layer (GL) it IS possible to observe Dpp II-posltlve pencytes associated with blood vessels (arrowheads) Figure 2 shows the effect of a loo-pg colchlcine InjectIon with a survival time of 1 hr Note (Fig. 1 ). In the cerebellar cortex, Purkinle cells and pericytes stain positively for Dpp II (Fig. 7) . In the medulla a number of neuronal nuclei stain positively for Dpp II; i.e., the nucleus ambiguus ( Fig. 9) , the superior olivary complex (Figs. 11 and 12) , and the lateral reticular nucleus (Fig. 18 ). In the midbrain, Dpp II staining occurs in the perikarya of magnocellular neurons of the red nucleus, with less intense staining in the neurons of the parvocellular region (Fig. 15) . The mesencephalic nucleus of the trigeminal nerve and the subceruleus also display intense perikaryal staining for Dpp II (see Fig. 22 ). In addition to these results, similar data were obtained for other brain regions which we previously reported to contain Dpp II (Gorenstein et al., 1981) .
Effect of colchicine on the localization of Dpp II. In an attempt to produce an accumulation of enzyme within cell bodies of neurons with low Dpp II activity, we utilized i.c.v. Injections of colchicine. In uninjected and saline-injected control rats, the cellular localization of Dpp II displays the same pattern of labeling as described above. However, when neurons were examined in colchicine-treated animals, we noted that colchicine induced an unexpected redistribution in the intraneuronal pattern of Dpp II staining (Fig. 4) . Thus, the mitral cells display a decrease of somal staining with a concomitant increase in dendritic staining (cf. Fig. 1 ). In the external plexiform layer, primary as well as secondary mitral cell dendrites now contain Dpp II reaction product. In addition to this phenomenon, colchicine produces a selective loss of granule cells from the granule cell layer wtthout any obvious effects on the mitral cells (cf. Figs. 5 and 6). It is interesting to note that the granule cells which normally contain little or no Dpp II reaction product are not stained in these colchicine preparations.
A similar redistribution of Dpp II staining is observed in virtually all neurons which contain the enzyme. In the presence of colchicine, dendrites become enriched with Dpp II whereas cell bodies become depleted of the enzyme. For example, in the cerebellar cortex, Purkinje cells which normally contain high concentrations of Dpp II in the cell body ( Fig. 7) display Dpp II in a polarized distribution, concentrated on the cellular pole from which dendrites arise (Fig. 8) .
Moreover, numerous dendrites that extend into the molecular layer also contain Dpp II reaction product in these colchicine preparations (Fig. 8) .
Other examples which exemplify this unusual phenomenon are the dendrites of the nucleus ambiguus (Figs. 9 and 10) and the superior olivary nucleus (Figs. 13 and 14) . In these cases, colchicine produces a near depletion of enzyme in cell bodies and permits the visualization of large portions of the dendritic arbor. In contrast, other brain regions display a more heterogeneous response to colchicine; for example, in the red nucleus the magnocellular neurons display intense dendritic and somal staining, whereas the parvocellular neurons show mainly dendritic staining (Fig. 16) .
A notable exception to the redistribution of Dpp II occurs in the mesencephalic nucleus of the trigeminal nerve. In this group of neurons colchicine has no effect on the degree of Dpp II somal staining (cf. Figs. 22 and 23) . It is interesting to note that these neurons comprise the only population of pseudo-unlpolar neurons in the brain and therefore lack dendrites.
that the mitral cell dendrites (arrows) now contain Dpp II reaction product. Figure 3 shows the effects of a loo-fig colchicine injection with a survival of 3 hr. Mitral cell bodies are nearly devoid of Dpp II reactlon product. Dendrites (arrows) extending into the external plexiform layer are labeled extensively with Dpp II Figure 4 shows the effect of a 100.pg InjectIon of colchlcine with a survival time of 24 hr. Mitral cell bodies In the ML are labeled, but to a lesser extent than that seen In Figures 1 and 2 . Dendrites (arrows) are extensively labeled with Dpp II reaction product and can be followed for a considerable distance into the external plexiform layer. Magniflcatlon X 175 for Figures 1 to 4 . Figures 5 and 6 . Effect of colchlclne on the morphology of the olfactory bulb. Figure 5 shows the normal Nissl-stained appearance of a brain section adjacent to that seen In Figure 1 . hgure 6 shows a Nlssl-stained section adjacent to that seen In Figure 4 and demonstrates the loss of granule cells from the granule cell layer (GL) after a 1 OO-pg colchicine inlectlon with a survival time of 24 hr. injection of 100 pg of colchicine, it is possible to detect a redistribution of Dpp II as early as 1 hr. This can be clearly seen in the mitral cell layer of the olfactory bulb (Fig. 2) . Three hours after the colchicine injection, marked dendritic staining that extends into the external plexiform layer is visible, and there is a drastic decrease in somal Dpp II staining (Fig. 3) . Twenty-four hours after a colchicine injection, somal Dpp II staining reappears and dendrites remain stained (Fig. 4) Recovery IS best seen in neurons of the red nucleus. Twenty-four hours after a 100.pg colchicine Injection there is dense Dpp II reaction product in both cell bodies and dendrites (Fig. 16 ). In contrast, 5 days after the colchicine qectlon only somal staining is observed (Fig. 17) .
Dose response of colchicine. Figure 7 7 the unlabeled white matter bundle on the ventral surface of this nucleus is the trapezoid body (TB). Magnification X 87. figure 12 is an enlargement of the box delineated in Figure 11 , Note the dense staining of somata for Dpp II reaction product. Magnification X 175. Dpp II starnrng predominates (Fig. 19 ) whereas at the highest dose it IS completely abolished (Fig. 21) . Redistr/but/on of acid phosphatase following colchicine treatment. To determine whether the effect of colchrcine was solely restncted to the redrstnbution of Dpp II or whether it represented a more generalized phenomenon, we investigated the effect of colchicine on the hrstochemical localization of acid phosphatase. All neurons which contain acid phosphatase also contain Dpp II, although not In the same relative concentration. Within neurons, acid phosphatase staining was observed in cell nuclei, cytoplasm, and, to a lesser extent, dendrites. A major difference in the cell pattern of drstrrbution of these two enzymes IS the large number of uniformly distributed glial cells which are only positive for acid phosphatase.
Following a IOO-yg i.c.v. injection of colchicine there is a rapid intracellular redistribution of acid phosphatase reaction product. This effect can be clearly observed in the dentate nucleus of the cerebellum (Figs. 24 and 25) ; somal staining is completely abolished, whereas dendritic staining is markedly enhanced. As was the case for Dpp II, colchicine does not produce a redistribution of acid phosphatase in neurons of the mesencephalic nucleus of the trigeminal nerve. This suggests that colchicine may be stimulating the transport of these two enzymes into dendrites through similar mechanisms
In vitro effect of colchicine on Dpp II activity. To determine whether the redistribution of Dpp II was a result of a direct interaction of colchicine with Dpp II, we investigated whether colchicine had a direct inhibitory effect on the enzymatic activity of Dpp II. Soluble brain extracts were treated with concentrations of colchicine equivalent to those used in vivo, and the effect on the enzymatic activity of Dpp II was measured fluorometrically. Table I shows that concen-Fjgures 75 and 76 Saglttal sections through the red nucleus of a rat showing magnocellular and parvocellular neurons (demarcated by dashed bnes) Fjgure 75 shows the normal dlstnbutlon of Dpp II in somata of both trations as high as 300 gg/ml of colchicine do not significantly affect the activity of Dpp II.
Discussion
Our main finding is the paradoxical effect which colchicine has on the intracellular distribution of two enzymes: Dpp Ii and acid phosphatase. Injections of colchicine into the lateral cerebral ventricles, known to produce a blockade of axonal and dendritic transport, produce a rapid and reversible translocation of these enzymes from their normal localization in the cell body to the dendrites. Although there is overwhelming evidence to indicate that colchicine has a profound inhibitory effect on the transport of many cellular constituents (Grafstein and Forman, 1980; Ochs, 1984) this study demonstrates that colchicine can, either directly or indirectly, stimulate the transport of certain lysosomal enzymes in neurons and suggests that enzyme translocation may be the result of a somatofugal movement of lysosomes from the cell body to the dendrites.
Dpp II and acid phosphatase are ubiquitous enzymes found in a large number of organs and cell types (Lojda et al., 1979) . Both enzymes have an acid pH optimum and are thought to be localized mainly to lysosomes (Smith, 1969; Smith and Van Frank, 1975; Sannes et al., 1979) . In the brain the histochemical distributions of acid phosphatase and Dpp II are very similar. All populations of neurons which contain Dpp II also contain acid phosphatase. However, major differences are observed in glial cells which only contain acid phosphatase. In neurons Dpp II and acid phosphatase are predominantly found in the cell body with comparatively little staining in dendrites. The physiological roles of acid phosphatase and Dpp II are unclear. In the brain, both of these enzymes display a highly localized distribution (Koenig, 1969; Gorenstein et al., 1981) suggestive of unique metabolic functions.
Following colchicine treatment there is a rapid redistribution of Dpp II from the cell body to the dendrites. As early as 1 hr following a colchicine injection it is possible to see this effect (Fig. 2) . This is striking in view of the distance separating the site of injection and some of the neuronai populations affected. This rapid action indicates that colchicine from the cerebrospinal fluid rapidly equilibrates in brain tissue.
The response of different neuronal populations to colchicine varies. In the olfactory bulb it is possible to observe patches of mitral cells displaying intense dendritic staining adjacent to areas where only somal staining is visible (not shown). This is most likely the result of uneven diffusion of colchicine throughout the olfactory bulb, since it is the cells most distant from the site of injection which display the somal staining. In other neuronal populations the effect of colchicine is also heterogeneous.
For example, in Purkinje cells of the cerebellum (Fig. 8 ) the nucleus ambiguus (Fig. IO) , and the red nucleus (Fig. 16 ) both somal and dendritic staining are observed, whereas in the superior olivary complex (Figs. 13 and 14) and the lateral reticular nucleus of the medulla (Fig. 20) somal staining is virtually absent and dendritic staining is pronounced.
The redistribution of Dpp II following colchicine treatment is dose dependent ,and reversible. At low doses of colchicine (25 pg) neurons display mainly somal Dpp II staining (Fig. 19) whereas at the highest dose used (400 pg) Dpp II reaction product is exclusively localized in dendrites (Fig. 21) . When rats are allowed to recover for 5 days after a 100.pg injection of colchicine there is a reduction in magnocellular (M) and parvocellular (P) neurons. Figure 78 shows Dpp II-labeled somata (arrows) in a control preparation. Figure 79 shows the effect of a 2.5pg colchicine injection. Significant numbers of cell bodies still show Dpp II staining (arrows), but dendritic staining is also prominent. Figure 20 shows the effect of a 1oO-~g colchicine injection. Most of the Dpp II activity is now in dendrites with only a few cell bodies remaining labeled (arrows). Figure 27 shows the effect of a 400~pg colchicine injection. the amount of somal labeling and an absence of dendritic staining (Fig. 17) indicating a return to the normal pattern of Dpp II staining. Examination of these neurons shows that the Dpp II reaction product IS more punctate in nature (Fig. 17) than that observed in control preparations, and probably represents a less aggregated form of Dpp II reaction product. We presently do not know whether the staining observed in these cells represents newly made enzyme or enzyme transported in retrograde fashion from the dendrites. Injections of colchicine directly into various brain areas have been shown to be neurotoxic and to produce cell loss. This effect is most pronounced in the granule cells of the olfactory bulb, hippocampus, and cerebellum (Goldschmidt and Steward, 1982) . Although we have also observed a loss of granule cells in the olfactory bulb in response to i.c.v. injections of colchicine (cf. Figs. 5 and 6) we have not observed an equivalent loss of neurons from the mitral cell layer. Also, we did not observe a significant loss of neuronal cell bodies in the red nucleus (Fig. 17) or in other Dpp II-containing cells examined 5 idays after a colchicine injection. Thus, we conclude that the redistribution of Dpp II is not accompanied by a loss of neuronal cell bodies which contain the enzyme.
Colchicine not only produces a redistribution of Dpp II but, in addition, appears to lower the total level of Dpp II activity in some brain regions as visualized by histochemical methods. This can be seen in Figures 3, 4 , 13, 14, and 21. One possible explanation is that colchicine inhibits Dpp II directly. This is apparently not the case since concentrations of colchicine as high as 300 rg/ml (equivalent to an i.c.v. injection of 600 pg of colchicine) did not produce a significant reduction in the in vitro activity of the enzyme (Table I) . Since colchicine has been reported to disrupt vesicle and enzyme transport from the Golgi apparatus to the plasma membrane (HindelangQertner et al., 1976; Odam and Ikehara, 1981; Redman et al., 1981) we suggest that the reduction in Dpp II activity observed 
